Antibe Therapeutics Inc(Pre-Merger) T.ATE

Alternate Symbol(s): ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

TSX:ATE - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Are New Variants On The Way?

<< Previous

Bullboard Posts

Next >>

Comment by YukonJezzaon Jul 10, 2021 1:54am

182 Views

Post# 33526039

RE:RE:RE:RE:RE:RE:Are New Variants On The Way?

Actuarial wrote: Covid is just a new flu. Nothing surprise. The virus has been existing in the earth for many many years, even longer than the history of human beings. And human don't have the technology to create it yet. Alike Spanish flu, who was able to make it? No body other than God!

btw 483 senior died in BC in one week BC last week from the heat wave. (Way more than any week of covid in BC) I guess there was no news because this wasn't pushing a drug agenda

<< Previous

Bullboard Posts

Next >>

One of the strongest contenders to lead Canada’s cannabis market